The business of fitness is entering a new phase—where profitability, affordability, and healthcare economics matter as much as growth.
Bank of America Is Spending $250M a Year on GLP-1s
Bank of America now spends more than $250M annually covering GLP-1 medications for its employees—roughly 13% of its entire healthcare budget.
- CEO Brian Moynihan called the expense “a good investment,” pointing to both weight loss and emerging evidence showing reductions in cardiovascular events.
- The company pairs medication access with health coaching and lifestyle support, negotiating lower prices while framing GLP-1s as a productivity and healthcare investment.
For years, employers viewed GLP-1s primarily as a cost problem. Now, the conversation is shifting from whether or not employers can afford GLP-1s to prioritizing access.
Peloton Reaches a Financial Milestone
Peloton posted its first-ever annual net profit, capping a years-long turnaround driven by cost discipline, price increases, and operational efficiency.
- Revenue topped expectations for the quarter, while the company generated positive operating income and free cash flow for the full fiscal year.
- Investors, however, focused on weaker guidance. Peloton expects revenue to decline next year as hardware demand remains soft, sending shares lower.
No longer fighting for survival, Peloton is proving it can build a sustainable business. The next challenge is reigniting growth as it expands into commercial fitness, partnerships, and what CEO Peter Stern calls a broader, connected wellness platform.
Planet Fitness Feels the Pressure
Planet Fitness lowered its profit outlook after slower-than-expected member sign-ups, even as systemwide sales exceeded expectations during the second quarter.
- The company plans to invest more heavily in marketing while testing new pricing, retention strategies, and member experiences to accelerate growth.
- The slowdown comes as analysts see a potential tailwind from lower-cost oral GLP-1s, which could encourage more first-time gym members to enter the market.
Taken together, today’s earnings paint a picture of a maturing industry.
Fitness companies are no longer judged simply by member growth. Investors are looking for pricing power, retention, profitability, and a clear role in a healthcare-driven ecosystem.
